Primary Sclerosing Cholangitis

Overview

Primary sclerosing cholangitis is a long-term disease that affects the bile ducts. Bile ducts are small tubes that carry bile, a digestive fluid, from the liver to the gallbladder and small intestine. In primary sclerosing cholangitis, these ducts become inflamed, scarred and narrowed over time. This can slow or block the flow of bile and may gradually damage the liver.

The condition is often referred to as PSC. It is usually a chronic condition, meaning it develops and progresses over years. Some people have mild symptoms or no symptoms for a long time, while others develop complications related to bile flow, liver function or infection. PSC is managed by specialists in gastroenterology and hepatology, often with long-term monitoring.

Symptoms

Symptoms can vary widely. Some people are diagnosed after abnormal liver blood tests, even before they feel unwell. When symptoms occur, they may include:

• Persistent tiredness or low energy
• Itching of the skin
• Yellowing of the skin or eyes, known as jaundice
• Dark urine or pale stools
• Discomfort or pain in the upper right side of the abdomen
• Fever or chills, especially if a bile duct infection occurs
• Unexplained weight loss or reduced appetite

Because PSC can affect bile drainage, it may also be associated with problems absorbing certain vitamins and nutrients. In more advanced disease, signs of liver scarring may appear, such as abdominal swelling, easy bruising or confusion. These symptoms require medical assessment.

Causes and Risk Factors

The exact cause of primary sclerosing cholangitis is not fully understood. It is thought to involve an abnormal immune response in which inflammation develops in the bile ducts. PSC is not caused by alcohol use, although alcohol may worsen liver problems in people who already have liver disease.

Risk factors and associated conditions may include:

• Inflammatory bowel disease, especially ulcerative colitis
• A personal or family history of autoimmune conditions
• Male sex, as PSC is more commonly diagnosed in men
• Diagnosis in early to middle adulthood, although it can occur at different ages

Not everyone with these risk factors develops PSC, and some people with PSC have no clear risk factor. The condition is not considered contagious and cannot be passed from person to person through contact.

Diagnosis

Diagnosis usually involves a combination of medical history, physical examination, blood tests and imaging tests. A doctor may ask about symptoms such as itching, jaundice, abdominal pain, bowel habits and any history of inflammatory bowel disease.

Blood tests can show how well the liver is working and whether there are signs of bile duct irritation or blockage. Imaging tests are important because they allow doctors to examine the bile ducts. A special type of magnetic resonance imaging may be used to look for narrowing or irregularity in the bile ducts. In some cases, an endoscopic procedure may be needed to examine or treat a narrowed duct.

Additional tests may be recommended to check for related conditions, assess the stage of liver disease or rule out other causes of bile duct problems. Sometimes a liver biopsy is considered, especially if the diagnosis is unclear or if doctors need more information about liver scarring.

Treatment Options

There is no single treatment that is suitable for everyone with primary sclerosing cholangitis. Care is usually focused on monitoring the disease, managing symptoms, treating complications and protecting liver health as much as possible.

Treatment and follow-up may include:

• Regular blood tests and imaging to monitor liver and bile duct health
• Management of itching, fatigue and nutritional concerns
• Assessment and treatment of bile duct narrowing when it causes significant blockage
• Treatment of bile duct infections if they occur
• Screening for complications related to the liver, bile ducts and bowel
• Care for associated inflammatory bowel disease, when present

Some people may need an endoscopic procedure to open or sample a narrowed bile duct. If liver disease becomes advanced, liver transplantation may be discussed as a treatment option. This decision depends on many individual factors and requires careful evaluation by a specialist team.

Lifestyle measures may support overall liver health. These include avoiding unnecessary alcohol, maintaining a balanced diet, staying physically active as tolerated and discussing vaccinations or supplements with a healthcare professional. Patients should not start or stop medicines or supplements without medical advice, because some products can affect the liver.

When to See a Doctor

People should seek medical advice if they develop persistent itching, yellowing of the skin or eyes, dark urine, pale stools, unexplained weight loss, ongoing fatigue or pain in the upper right abdomen. Anyone with known PSC should contact their healthcare team if symptoms change or become worse.

Urgent medical attention is needed for fever, chills, severe abdominal pain, confusion, vomiting blood, black stools or sudden worsening of jaundice. These symptoms may indicate infection, bleeding or significant liver-related complications.

Primary sclerosing cholangitis is a complex condition, but regular specialist follow-up can help detect changes early and guide appropriate care. International patients may benefit from bringing previous blood tests, imaging reports, endoscopy results and records of any bowel disease to their medical appointment.

Frequently Asked Questions

What is primary sclerosing cholangitis?

Primary sclerosing cholangitis, often called PSC, is a long-term liver disease in which the bile ducts that carry bile from the liver to the gallbladder and intestine become inflamed, scarred and narrowed over time. This slows or blocks bile flow and may gradually damage the liver. It usually develops over years; some people have no symptoms for a long time, while others develop complications of bile flow, liver function or infection.

What are the symptoms of primary sclerosing cholangitis?

Some people are diagnosed after abnormal liver blood tests before they feel unwell. When symptoms occur they may include persistent tiredness, itching of the skin, jaundice with yellowing of the skin or eyes, dark urine or pale stools, discomfort in the upper right abdomen, fever or chills when a bile duct infection develops, and unexplained weight loss. In advanced disease, signs of liver scarring such as abdominal swelling, easy bruising or confusion can appear.

What causes primary sclerosing cholangitis?

The exact cause is not fully understood. It is thought to involve an abnormal immune response that produces inflammation in the bile ducts. It is strongly associated with inflammatory bowel disease, especially ulcerative colitis, and with a personal or family history of autoimmune conditions. It is more commonly diagnosed in men and in early to middle adulthood. It is not caused by alcohol and is not contagious, although alcohol can worsen existing liver disease.

How is primary sclerosing cholangitis diagnosed?

Diagnosis combines medical history, physical examination, blood tests showing bile duct irritation or blockage and imaging of the bile ducts. A specialised MRI called magnetic resonance cholangiography shows the characteristic narrowing and irregularity of the ducts. An endoscopic procedure may be used to examine or treat a narrowed duct. Additional tests check for inflammatory bowel disease and assess liver scarring, and a liver biopsy is considered when the diagnosis is unclear.

How is primary sclerosing cholangitis treated?

There is currently no medicine proven to cure PSC or reliably halt its progression, so management focuses on monitoring liver function and complications, relieving symptoms such as itching, treating bile duct infections promptly, correcting vitamin deficiencies and opening significant duct narrowings endoscopically when needed. Regular surveillance for bile duct and bowel cancer is part of care. In advanced disease, liver transplantation offers good long-term outcomes and is planned by a hepatology team.